Cite
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome.
MLA
D’Alò, Francesco, et al. “Response to 5-Azacytidine in a Patient with Relapsed Hodgkin Lymphoma and a Therapy-Related Myelodysplastic Syndrome.” British Journal of Haematology, vol. 154, no. 1, July 2011, pp. 141–43. EBSCOhost, https://doi.org/10.1111/j.1365-2141.2010.08438.x.
APA
D’Alò, F., Leone, G., Hohaus, S., Teofili, L., Bozzoli, V., Tisi, M. C., Rufini, V., Calcagni, M. L., & Voso, M. T. (2011). Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome. British Journal of Haematology, 154(1), 141–143. https://doi.org/10.1111/j.1365-2141.2010.08438.x
Chicago
D’Alò, Francesco, Giuseppe Leone, Stefan Hohaus, Luciana Teofili, Valentina Bozzoli, Maria Chiara Tisi, Vittoria Rufini, Maria Lucia Calcagni, and Maria Teresa Voso. 2011. “Response to 5-Azacytidine in a Patient with Relapsed Hodgkin Lymphoma and a Therapy-Related Myelodysplastic Syndrome.” British Journal of Haematology 154 (1): 141–43. doi:10.1111/j.1365-2141.2010.08438.x.